These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 9770573)

  • 1. Rapamycin (sirolimus) inhibits heart cell growth in vitro.
    Burton PB; Yacoub MH; Barton PJ
    Pediatr Cardiol; 1998; 19(6):468-70. PubMed ID: 9770573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition by rapamycin of PDGF- and bFGF-induced human tenon fibroblast proliferation in vitro.
    Salas-Prato M; Assalian A; Mehdi AZ; Duperré J; Thompson P; Brazeau P
    J Glaucoma; 1996 Feb; 5(1):54-9. PubMed ID: 8795734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute systemic rapamycin induces neurobehavioral alterations in rats.
    Hadamitzky M; Herring A; Keyvani K; Doenlen R; Krügel U; Bösche K; Orlowski K; Engler H; Schedlowski M
    Behav Brain Res; 2014 Oct; 273():16-22. PubMed ID: 25043732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin inhibits proliferation and migration of hepatoma cells in vitro.
    Shirouzu Y; Ryschich E; Salnikova O; Kerkadze V; Schmidt J; Engelmann G
    J Surg Res; 2010 Apr; 159(2):705-13. PubMed ID: 19482307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zotarolimus, a novel sirolimus analogue with potent anti-proliferative activity on coronary smooth muscle cells and reduced potential for systemic immunosuppression.
    Chen YW; Smith ML; Sheets M; Ballaron S; Trevillyan JM; Burke SE; Rosenberg T; Henry C; Wagner R; Bauch J; Marsh K; Fey TA; Hsieh G; Gauvin D; Mollison KW; Carter GW; Djuric SW
    J Cardiovasc Pharmacol; 2007 Apr; 49(4):228-35. PubMed ID: 17438408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirolimus, a new potent immunosuppressant agent for refractory cardiac transplantation rejection: two case reports.
    Haddad H; MacNeil DM; Howlett J; O'Neill B
    Can J Cardiol; 2000 Feb; 16(2):221-4. PubMed ID: 10694593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin inhibits cholangiocyte regeneration by blocking interleukin-6-induced activation of signal transducer and activator of transcription 3 after liver transplantation.
    Chen LP; Zhang QH; Chen G; Qian YY; Shi BY; Dong JH
    Liver Transpl; 2010 Feb; 16(2):204-14. PubMed ID: 20104495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolving experience using everolimus in clinical transplantation.
    Formica RN; Lorber KM; Friedman AL; Bia MJ; Lakkis F; Smith JD; Lorber MI
    Transplant Proc; 2004 Mar; 36(2 Suppl):495S-499S. PubMed ID: 15041395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocyte enlargement, differentiation, and proliferation kinetics in the fetal sheep heart.
    Jonker SS; Zhang L; Louey S; Giraud GD; Thornburg KL; Faber JJ
    J Appl Physiol (1985); 2007 Mar; 102(3):1130-42. PubMed ID: 17122375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of T and B lymphocyte proliferation by rapamycin.
    Kay JE; Kromwel L; Doe SE; Denyer M
    Immunology; 1991 Apr; 72(4):544-9. PubMed ID: 1709916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of low-dose rapamycin on tumor growth in two human hepatocellular cancer cell lines.
    Heuer M; Benkö T; Cicinnati VR; Kaiser GM; Sotiropoulos GC; Baba HA; Treckmann JW; Broelsch CE; Paul A
    Transplant Proc; 2009; 41(1):359-65. PubMed ID: 19249557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fetal human myocardium. Proliferation of the myocytes and development of the cardiac interstitium in the last two gestational trimesters].
    dos Santos MB; Mandarim-de-Lacerda CA
    Arq Bras Cardiol; 1997 Feb; 68(2):99-102. PubMed ID: 9433834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin impairs in vivo proliferation of islet beta-cells.
    Zahr E; Molano RD; Pileggi A; Ichii H; Jose SS; Bocca N; An W; Gonzalez-Quintana J; Fraker C; Ricordi C; Inverardi L
    Transplantation; 2007 Dec; 84(12):1576-83. PubMed ID: 18165767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapamycin impairs beta-cell proliferation in vivo.
    Zahr E; Molano RD; Pileggi A; Ichii H; San Jose S; Bocca N; An W; Gonzalez-Quintana J; Fraker C; Ricordi C; Inverardi L
    Transplant Proc; 2008 Mar; 40(2):436-7. PubMed ID: 18374093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapamycin inhibits release of tumor necrosis factor-alpha from human vascular smooth muscle cells.
    Adkins JR; Castresana MR; Wang Z; Newman WH
    Am Surg; 2004 May; 70(5):384-7; discussion 387-8. PubMed ID: 15156944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes.
    Khan S; Salloum F; Das A; Xi L; Vetrovec GW; Kukreja RC
    J Mol Cell Cardiol; 2006 Aug; 41(2):256-64. PubMed ID: 16769083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trk C receptor signaling regulates cardiac myocyte proliferation during early heart development in vivo.
    Lin MI; Das I; Schwartz GM; Tsoulfas P; Mikawa T; Hempstead BL
    Dev Biol; 2000 Oct; 226(2):180-91. PubMed ID: 11023679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible mechanism by which rapamycin increases cyclosporine nephrotoxicity.
    Cheng CH; Chang HR; Chiang CW; Shu KH; Chou MC
    Transplant Proc; 2008 Sep; 40(7):2373-5. PubMed ID: 18790238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New advances in antirejection therapy.
    Chan M; Pearson GJ
    Curr Opin Cardiol; 2007 Mar; 22(2):117-22. PubMed ID: 17284990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin-induced phosphaturia.
    Kempe DS; Dërmaku-Sopjani M; Fröhlich H; Sopjani M; Umbach A; Puchchakayala G; Capasso A; Weiss F; Stübs M; Föller M; Lang F
    Nephrol Dial Transplant; 2010 Sep; 25(9):2938-44. PubMed ID: 20368307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.